We're proud to share the launch of the Opioid Addiction Deterrence Task Force (OADTF) by the American Medical Technology Coalition, led by Custom Health. The newly founded OADTF is focused on accelerated opioid addiction deterrence strategies rooted in cutting-edge research, technology, and a solutions-based approach.
Read Custom Health's full press release here: https://bit.ly/3SmK6AS
Read the AMTC's full press release here: https://bit.ly/3WylMOO
Remarks from Task Force leaders:
Our goal is to harness the power of medical technology to deter addiction through safe, accountable use of prescription medication and rapid access to support systems for those affected by opioid use disorder. This initiative reflects our commitment to addressing critical healthcare challenges through innovation and collaboration.
Shane Bishop, CEO Custom Health
We're honored to join the OADTF as a core technology partner. Healent, a leader in AI-driven clinical intelligence for pain management, is committed to reducing opioid impacts. The Task Force's vision aligns with our mission.
Mike Palackdharry, CEO Healent
Persona's tech stack, featuring the world's most advanced data transformation engine, creates valuable datasets that drive improved health outcomes. This structured, standardized data forms the foundation for high-value operations like machine learning and AI, enhancing our ability to address the most pressing healthcare issues.
Nick Egahos, CEO Persona
I look forward to this first of its kind collaboration between clinicians, lawmakers, and medical technology to improve the lives of chronic pain patients managed with opioids. I can't wait to see the progress that we can make with our combined resources.
Dr. Kyle Young, CEO Commonwealth Pain & Spine
